- Home
- UNP vs MRK Comparison
UNP vs MRK Comparison
Compare UNP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNP | MRK |
|---|---|---|
| Founded | 1862 | 2000 |
| Country | United States | United States |
| Employees | N/A | 75000 |
| Industry | Railroads | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.1B | 281.2B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | UNP | MRK |
|---|---|---|
| Price | $258.74 | $119.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 17 |
| Target Price | ★ $275.55 | $125.59 |
| AVG Volume (30 Days) | 2.9M | ★ 8.6M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 2.08% | ★ 3.06% |
| EPS Growth | ★ 8.03 | 8.01 |
| EPS | ★ 2.87 | N/A |
| Revenue | $19,533,000,000.00 | ★ $65,011,000,000.00 |
| Revenue This Year | $5.57 | $3.61 |
| Revenue Next Year | $4.29 | $5.41 |
| P/E Ratio | $90.56 | ★ N/A |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $214.32 | $76.66 |
| 52 Week High | $279.70 | $125.14 |
Technical Indicators
Market Signals| Indicator | UNP | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 55.78 |
| Support Level | $217.43 | $112.96 |
| Resistance Level | $272.75 | $123.93 |
| Average True Range (ATR) | 6.45 | 2.97 |
| MACD | -1.47 | -0.28 |
| Stochastic Oscillator | 18.88 | 64.09 |
Price Performance
Historical ComparisonAbout UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24.5 billion of revenue in 2025 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).